Each injection should be reported separately
In contrast, when bound to transcobalamin II, the half-life is significantly shorter, approximately 1.5 hours, although the final plasma curves for both forms yield similar half-life values of around 9.3 to 9.8 days due to the rapid reappearance of the radiocobalt label bound to transcobalamin I
Inability of some commercial assays to measure suppression of glucagon secretion
Aoun L, Almardini S, Saliba F, et al
Other markers are not commonly measured either in clinical practice or in many clinical trials, making it difficult to interpret whether positive outcomes in some studies are due to correcting a deficiency or due to other pharmacological functions of B12
AnsseauMvon FrenckellRCerfontaineJLPapartP